Toronto Dominion Bank
BBOT

Toronto Dominion Bank’s BridgeBio Oncology BBOT Stock Holding History

Toronto Dominion Bank’s Portfolio BBOT Stock Details BBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-444,377
Closed -$4.72M – 2126
2025
Q2 		$4.72M Buy
444,377
+306,377
+222% +$3.31M 0.01% 758
2025
Q1 		$1.56M Buy
138,000
+88,500
+179% +$951K ﹤0.01% 998
2024
Q4 		$520K Buy
+49,500
New +$521K ﹤0.01% 1173

Other funds holding BBOT

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Toronto Dominion Bank's BBOT Position: Q3 2025 in Review

Toronto Dominion Bank sold out of BridgeBio Oncology (BBOT) in Q3 2025, closing a stake of 444,377 shares — an estimated $4.72M sold.

Toronto Dominion Bank first reported a position in BBOT in Q4 2024 and held it in 3 quarters. The position peaked at $4.72M in Q2 2025. 42 funds tracked by Wall St. Rank hold BBOT as of Q3 2025.

  • Toronto Dominion Bank reported no remaining BridgeBio Oncology position as of Q3 2025 after selling out during the quarter.
  • Toronto Dominion Bank sold 444,377 BridgeBio Oncology shares in Q3 2025, an estimated $4.72M.
  • Toronto Dominion Bank first reported a position in BridgeBio Oncology in Q4 2024 and held it in 3 quarters.
  • Toronto Dominion Bank's BridgeBio Oncology position peaked at $4.72M in Q2 2025.
  • 42 funds tracked by Wall St. Rank held BridgeBio Oncology as of Q3 2025.

Based on Toronto Dominion Bank's 13F filing for Q3 2025, filed 14 Nov 2025.